Ind-Swift Laboratories Limited has informed the Exchange about the update on the Second Motion Petition for approval of Scheme of Arrangement
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ind-Swift Laboratories has informed the stock exchange about an update to its Second Motion Petition filed before the National Company Law Tribunal (NCLT) seeking approval for a Scheme of Arrangement. A Second Motion Petition typically follows shareholder and creditor approvals and represents the final hearing stage for the scheme's sanction. The company has not disclosed detailed terms of the arrangement in this headline, such as any demerger ratio or specific restructuring details. Investors may need to refer to earlier filings or the company's detailed disclosure for full context.
This filing is procedural and does not by itself change the business or financials. Shareholders should await NCLT approval and further disclosures to understand whether the arrangement involves a demerger, merger, or capital restructuring, any of which could affect the shareholding pattern or the stock price.